Niko Receives Conversion Notice

zhaopinboai.com
DUBLIN (AP) _ Amarin Corp. PLC (AMRN) on Thursday reported a loss of $24.5 million in its third quarter. On a per-share basis, the Dublin-based company said it had a loss of 8 cents. Losses, adjusted for stock option expense, came to 6 cents per share. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share. The biopharmaceutical company posted revenue of $55.3 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $61.5 million. Amarin shares have climbed fivefold since the beginning of the year. The stock has risen sixfold in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN View comments
Science and Engineering: Understanding Their Unique Roles
Explore the fundamental differences between science and engineering, and how they relate to our interests and nature.